EP2805720
NF-KB sterastillar sem ekki eru hormónar til meðferðar á sjúkdómum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.5.2009EP published:
7.8.2019EP application number:
14173342.8
EP translation filed:
13.8.2019Grant published:
15.9.2019EPO information:
European Patent Register
Max expiry date:
27.5.2029Expiry date:
27.5.2026Next due date:
31.5.2026
Title:
Non-hormonal steroid modulators of NF-KB for treatment of disease
Timeline
Today
28.5.2009EP application
7.8.2019EP Publication
13.8.2019Translation submitted
15.9.2019Registration published
27.5.2026Expires
Owner
Name:
ReveraGen BioPharma, Inc.Address:
155 Gibbs Street, Suite 433, 20850, Rockville, MD, US
Inventor
Name:
Mccall, John, M.Address:
Kensington, MD, US
Name:
Hoffman, EricAddress:
Kensington, MD, US
Name:
Kanneboyina, NagarajuAddress:
Kensington, MD, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
56715 PDate:
28.5.2008Country:
US
Supplementary protection
SPC number:
SPC468
Classification
Categories:
A61K 31/575, A61P 21/00, A61P 19/02, A61P 11/06
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 30.4.2020
Expires: 27.5.2021
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 3.5.2021
Expires: 27.5.2022
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 3.5.2022
Expires: 27.5.2023
Payer: Patice ehf.
Number: 15
Paid: 23.5.2023
Expires: 27.5.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 7.5.2024
Expires: 27.5.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 12.6.2025
Expires: 27.5.2026
Payer: Árnason Faktor ehf.